articleThe LancetJul 1, 2009Closed access

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

University of Helsinki · Hospital de Clínicas de Porto Alegre · +30 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,651
total citations
FWCI
103.89
Percentile
100%
References
33
Citations per year

Authors

27

Topics & keywords

Keywords
  • Medicine
  • Cohort
  • Interim analysis
  • Cervical cancer
  • Vaccine efficacy
  • Clinical endpoint
  • Vaccine trial
  • Population
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding